bioRxivBiochemistry
Structural insights into the interaction of heme with protein tyrosine kinase JAK2
Abstract
Janus kinase 2 (JAK2) is the most important signal transducing tyrosine kinase in erythropoietic precursor cells. Its malfunction drives several myeloproliferative disorders. Heme is a small metal ion-carrying molecule, which is incorporated into hemoglobin in erythroid precursor cells to transport oxygen. In addition, heme is a signaling molecule and regulator of various biochemical processes. Here we show that heme exposure leads to hyperphosphorylation of JAK2 in a myeloid cancer cell line. Two peptides identified in JAK2 represent heme-regulatory motifs and show low micromolar affinities for heme. These peptides map to the kinase domain of JAK2, which is essential for downstream signaling. We suggest these motifs to be the interaction sites of heme with JAK2, which drive the heme-induced hyperphosphorylation. The results presented herein may facilitate the development of heme-related pharmacological tools to combat myeloproliferative disorders.
- organism: human
- assay: proteomics
- research focus: host-pathogen & immune response
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- PITPβ Drives JAK2 V617F-Mediated Myeloproliferative Neoplasms by Promoting PtdIns(3,4)P2-Dependent AKT Hyperactivation
Nikita Vantsev, Liang Zhao, … Wei Tong·bioRxiv·Mar 30, 2026
- Hipk is required for JAK/STAT activity and promotes hemocyte-derived tumorigenesis
Jessica A. Blaquiere, Nathan B. Wray, Esther M. Verheyen·bioRxiv·Jun 10, 2016
- Jak2V617F Reversible Activation Shows an Essential Requirement for Jak2V617F in Myeloproliferative Neoplasms
A. Dunbar, R. L. Bowman, … R. L. Levine·bioRxiv·May 18, 2022
- Mechanism of hyperproteinemia-induced blood cell homeostasis imbalance in an animal model
- HIF-1 activated by PIM1 assembles a pathological transcription complex and regulon that drives JAK2V617F MPN disease
David Kealy, Ruth Ellerington, … Katherine S. Bridge·LeukemiaPeer-reviewed·Feb 2, 2026
- A murine model with JAK2V617F expression in both hematopoietic cells and vascular endothelial cells recapitulates the key features of human myeloproliferative neoplasm